Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer - Concepedia

Concepedia

Publication | Open Access

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

DOI Full Paper Access

217

Citations

19

References

2004

Year

Ramesh K. Ramanathan, Kenneth Lee, John McKolanis, Elizabeth Hitbold, Wolfgang H. Schraut, A. James Moser, Elizabeth Warnick, Theresa L. Whiteside, Jennifer Osborne, Hyoung Kim,

Cancer Immunology Immunotherapy

Muc1 PeptidePancreatic CancerMedicineImmunologyTumor ImmunityTherapeutic VaccinePancreatic SurgeryMuc1 VaccineImmunotherapeuticsAdvanced Pancreatic CancerOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1